INTRODUCTION {#s1}
============

The remarkable versatility of Ca^2+^ as an intracellular messenger is underpinned by the spatiotemporal organisation of Ca^2+^ signals ([@JCS190322C3]). Targeted delivery of Ca^2+^ to a particular subcellular locale is one way in which Ca^2+^ can selectively influence a particular cell outcome (e.g. secretion). Equally, global Ca^2+^ signals, which are often oscillatory, can also be selective through information encoded in oscillation frequency. Interplay between Ca^2+^ release from intracellular Ca^2+^ stores and Ca^2+^ influx from the extracellular space ensures tight control of Ca^2+^ levels and their downstream targets ([@JCS190322C10]). Although we have gained much mechanistic insight into the mobilisation of ER Ca^2+^ stores and the subsequent entry of Ca^2+^ across the plasma membrane that ensues ([@JCS190322C37]), we know relatively little about Ca^2+^ handling by acidic Ca^2+^ stores such as lysosomes ([@JCS190322C34]).

Lysosomes are best known for their degradative role but they maintain an intraluminal Ca^2+^ concentration (∼500 µM) similar to the ER ([@JCS190322C9]; [@JCS190322C26]). They are likely filled by Ca^2+^-H^+^ exchange ([@JCS190322C29]) and express members of the transient receptor potential mucolipin (TRPML) and two-pore channel (TPC) families to effect Ca^2+^ release ([@JCS190322C18]; [@JCS190322C24]; [@JCS190322C31]; [@JCS190322C44]). Three TRPML isoforms are present in humans ([@JCS190322C15]). TRPML1 (encoded by *MCOLN1*) is ubiquitously expressed and targets to lysosomes through di-leucine motifs ([@JCS190322C43]). It is activated by the endo-lysosomal phosphoinositide phosphatidylinositol 3,5-bisphosphate \[PI(3,5)P~2~\] ([@JCS190322C12]) and is a non-selective cation channel permeable to a number of ions including Ca^2+^ and Fe^2+^ ([@JCS190322C11]). Importantly, mutation of TRPML1 results in the lysosomal storage disorder mucolipidosis type IV ([@JCS190322C2]). This neurodegenerative disorder is characterised by build-up of various lipid species in lysosomes, suggesting a role for TRPML1 in lipid trafficking. It has long been recognised that localised Ca^2+^ release from the endo-lysosomal system can influence vesicular fusion and fission events ([@JCS190322C38]). Specifically, Ca^2+^ release through TRPMLs likely underlies functional roles in vesicular trafficking as well as lysosomal exocytosis ([@JCS190322C39]), autophagy ([@JCS190322C28]) and regulated secretion ([@JCS190322C30]). Notably, recently described TRPML agonists have proven beneficial in correcting trafficking defects not only in mucolipidosis type IV ([@JCS190322C8]) but also in Niemann--Pick type C disease ([@JCS190322C40]) and HIV-associated dementia ([@JCS190322C1]). Defective TRPML activity has also been implicated in Alzheimer\'s disease ([@JCS190322C25]). Despite their demonstrable (patho)physiological relevance, TRPML-mediated Ca^2+^ signals are difficult to resolve due to their localised nature. To overcome this, a number of recent studies have used genetically encoded Ca^2+^ indicators such as GCaMP-3 or GECO fused directly to TRPML1 to record Ca^2+^ signals in response to agonist activation ([@JCS190322C1]; [@JCS190322C7]; [@JCS190322C28]; [@JCS190322C40]). These signals are suggested to reflect local peri-lysosomal Ca^2+^ release. But it is not clear how the relatively high-affinity Ca^2+^ indicators used distinguish between local and global Ca^2+^ signals.

In addition to supporting local Ca^2+^ fluxes required for endocytic 'well-being' ([@JCS190322C20]), lysosomes can also initiate global Ca^2+^ signals during signalling. This process has been established in the context of the actions of the messenger nicotinic acid adenine dinucleotide phosphate (NAADP) ([@JCS190322C14]). According to the trigger hypothesis, increases in NAADP levels activate endo-lysosomal Ca^2+^ channels, generating local Ca^2+^ signals that sensitise neighbouring Ca^2+^ release channels on the ER. Activation of the latter (on the more substantial store) results in global Ca^2+^ release. Indeed, in fibroblasts, direct mobilisation of lysosomal Ca^2+^ stores through osmotic permeabilisation is sufficient to trigger ER-dependent complex Ca^2+^ signals ([@JCS190322C22]). Physiologically, it is the TPCs that have emerged as the target channels for NAADP ([@JCS190322C4]; [@JCS190322C5]; [@JCS190322C31]) although a role for TRPMLs has also been advanced ([@JCS190322C46], but see [@JCS190322C45]). Coupling between TPCs and ER Ca^2+^ channels likely occurs at membrane contact sites between lysosomes and the ER ([@JCS190322C22]; [@JCS190322C32]; [@JCS190322C36]). Although TRPMLs can evoke global Ca^2+^ entry, at least when mutated as exemplified by the Va mutation in TRPML3 (encoded by *MCOLN3*) ([@JCS190322C16]; [@JCS190322C23]), whether they support lysosome--ER cross talk is not known.

Here, we take advantage of TRPML agonists ML-SA1 ([@JCS190322C40]) and MK6-83 ([@JCS190322C8]) to probe the Ca^2+^ permeability of TRPMLs in an intact cell setting. We show that activation of TRPML1 unexpectedly evokes global Ca^2+^ signals. Mechanistically, we dissect these signals into release and influx components implicating both ER and extracellular Ca^2+^, in addition to lysosomal Ca^2+^, for their genesis. Our data suggest that the action of TRPML1 is not limited to local lysosomal Ca^2+^ signalling.

RESULTS {#s2}
=======

TRPML agonists evoke global Ca^2+^ signals {#s2a}
------------------------------------------

Fusion proteins comprising TRPML1 and either GCaMP-3 ([@JCS190322C40]) or GECO ([@JCS190322C7]) have been used to resolve presumed local Ca^2+^ fluxes from lysosomes upon TRPML1 activation. But as shown in [Fig. 1](#JCS190322F1){ref-type="fig"}A and [Movie 1](Movie 1), Ca^2+^ responses to ML-SA1 (20 µM) were readily resolvable in a proportion of Hela cells loaded with the fluorescent Ca^2+^ indicator Fura-2. This organic dye distributes throughout the cytosol and thus records bulk changes in cytosolic Ca^2+^. ML-SA1 responses were concentration dependent ([Fig. 1](#JCS190322F1){ref-type="fig"}A). Similar results were obtained using primary cultured human fibroblasts. As in HeLa cells, ML-SA1 evoked strong Ca^2+^ responses in Fura-2-loaded cells in a concentration-dependent manner ([Fig. 1](#JCS190322F1){ref-type="fig"}B; [Movie 2](Movie 2)). The amplitude of the Ca^2+^ signals and the proportion of responsive cells are quantified in [Fig. 1](#JCS190322F1){ref-type="fig"}C,D. Fibroblasts were more responsive than HeLa cells, although we noted considerable variability between experiments, particularly for fibroblasts ([Fig. 1](#JCS190322F1){ref-type="fig"}D). To probe specificity, we examined the effects of the new TRPML antagonists ML-SI1 and ML-SI3 ([@JCS190322C39]). ML-SI1 could not be used because it evoked Ca^2+^ signals ([Fig. S1A](Fig. S1A)). ML-SI3, however, inhibited ML-SA1-evoked Ca^2+^ signals ([Fig. 1](#JCS190322F1){ref-type="fig"}E,F). Collectively, these data suggest that, contrary to the prevailing view, activation of endogenous TRPMLs is capable of evoking global Ca^2+^ signals. Fig. 1.**The TRP mucolipin agonist ML-SA1 evokes global Ca^2+^ signals.** (A--D) Effect of ML-SA1 on cytosolic Ca^2+^ levels. Cytosolic Ca^2+^ levels of individual Fura-2-loaded HeLa cells (A) or fibroblasts (B) from an exemplar population stimulated with increasing concentrations of ML-SA1. (C,D) Summary data quantifying the peak response (C) and percentage of responsive cells within the population (D). Each data point represents an independent repetition. A total of 350--788 HeLa cells and 81--140 fibroblasts were analysed. (E,F) Effect of the mucolipin inhibitor ML-SI3 on agonist-evoked Ca^2+^ signals. (E) Cytosolic Ca^2+^ levels of HeLa cells stimulated with 20 µM ML-SA1 in the presence of vehicle (0.1% DMSO) or 10 µM ML-SI3. (F) Summary data for the experiments in E (366--406 cells).

Agonist-evoked Ca^2+^ signals require TRPML1 {#s2b}
--------------------------------------------

To investigate the mechanism underlying agonist-evoked Ca^2+^ signals, we examined the effects of expressing active TRPML1 and inactive TRPML1 mutated within the pore region (TRPML1^D471K^) ([@JCS190322C45]). Confocal analyses of HeLa cells expressing TRPML1 and TRPML1^D471K^ revealed a comparable punctate distribution consistent with localisation to lysosomes ([Fig. 2](#JCS190322F2){ref-type="fig"}A). Accordingly, there was marked colocalisation of both proteins with lysotracker (a fluorescent acidotrope) and LAMP1 (a lysosomal marker) ([Fig. 2](#JCS190322F2){ref-type="fig"}B--E). Fig. 2.**Subcellular distribution of TRPML1.** (A) Confocal fluorescence images (green) of fixed HeLa cells expressing GFP-tagged LAMP1 (left), TRPML1 (middle) or TRPML1^D471K^ (right). Nuclei were stained using DAPI (blue). (B,C) Confocal fluorescence images of cells expressing GFP--TRPML1 or GFP--TRPML1^D471K^ and either colabelled with Lysotracker^®^ Red (LTR) and imaged live (B) or co-transfected with LAMP1-mRFP and imaged following fixation (C). Overlays of images are shown in the right panels where arrows delineate the regions from which red--green intensity plots were derived. Scale bar: 10 µm. (D,E) Summary data of experiments in C quantifying Pearson\'s correlation coefficients (D) and the percentage of vesicles showing colocalisation (E). Each point represents an individual cell from two independent transfections.

In control experiments, ML-SA1 evoked Ca^2+^ signals in cells expressing LAMP1 ([Fig. 3](#JCS190322F3){ref-type="fig"}A). The responses were similar to those in un-transfected cells ([Fig. 1](#JCS190322F1){ref-type="fig"}). In cells expressing TRPML1, however, there was a large potentiation of the Ca^2+^ signal ([Fig. 3](#JCS190322F3){ref-type="fig"}A) such that essentially all of the cells responded ([Fig. 3](#JCS190322F3){ref-type="fig"}B,C). The potentiating effect of TRPML1 was specific because it was not observed with TRPML1^D471K^ ([Fig. 3](#JCS190322F3){ref-type="fig"}A--C). Similar results were obtained in fibroblasts ([Fig. S1C,D](Fig. S1C,D)) although this analysis was more limited due to the difficulty in transfecting these cells. Notably, ML-SA1-evoked Ca^2+^ signals were inhibited in cells expressing TRPML1^D471K^ relative to cells expressing LAMP1 ([Fig. 3](#JCS190322F3){ref-type="fig"}A--C). The inhibitory effect of TRPML1^D471K^ is likely due to dominant-negative activity resulting from oligomerisation with endogenous TRPML1 ([@JCS190322C42]). Fig. 3.**Agonist-evoked Ca^2+^ signals require TRPML1.** (A--C) Effect of TRPML expression on ML-SA1-evoked Ca^2+^ signals. (A) Cytosolic Ca^2+^ levels of individual LAMP1, TRPML1- or TRPML1^D471K^-expressing HeLa cells stimulated with 20 µM ML-SA1. (B,C) Summary data of experiments in A where each data point represents an independent repetition. The total number of cells analysed was 193--367. (D,E) Effect of TRPML expression on MK6-83-evoked Ca^2+^ signals. (D) Cytosolic Ca^2+^ levels of individual TRPML1- or TRPML1^D471K^-expressing HeLa cells stimulated with 20 µM MK6-83. (E) Summary data of experiments in D (111--128 cells). (F--I) Effect of ML-SI3 on agonist-evoked Ca^2+^ signals. Cytosolic Ca^2+^ levels of individual TRPML1-expressing HeLa cells stimulated with 20 µM ML-SA1 (F) or 20 µM MK6-83 (H) in the presence of vehicle (0.1% DMSO) or 10 µM ML-SI3. Summary data are shown in panels (G; 120 cells) and (I; 101--107 cells), respectively.

We also tested the effect of the structurally distinct mucolipin analogue MK6-83. Like ML-SA1, MK6-83 evoked large Ca^2+^ signals in cells expressing TRPML1 but not TRPML1^D471K^ ([Fig. 3](#JCS190322F3){ref-type="fig"}D,E). Ca^2+^ signals evoked by both ML-SA1 and MK6-83 in TRPML1-expressing cells were blocked by ML-SI3 ([Fig. 3](#JCS190322F3){ref-type="fig"}F--I). These molecular and chemical analyses establish the requirement for TRPML1 in global Ca^2+^ signalling.

TRPML1 couples lysosomal and ER Ca^2+^ release {#s2c}
----------------------------------------------

To define the Ca^2+^ sources underlying TRPML1-dependent Ca^2+^ signals, we first established the relative contribution of store release and Ca^2+^ entry to the evoked responses. As shown in [Fig. 4](#JCS190322F4){ref-type="fig"}A,B, removal of extracellular Ca^2+^ reduced the peak response upon ML-SA1 stimulation and eliminated the sustained phase. ML-SA1-evoked Ca^2+^ signals in Ca^2+^-free medium were TRPML1 dependent, as judged by the lack of ML-SA1-evoked Ca^2+^ signals in TRPML1^D471K^-expressing cells and upon treatment with ML-SI3 ([Fig. 4](#JCS190322F4){ref-type="fig"}C). These data suggest that ML-SA1 evokes both Ca^2+^ release and Ca^2+^ influx. Fig. 4.**TRPML1 couples lysosomal and ER Ca^2+^ release.** (A,B) Effect of extracellular Ca^2+^ on agonist-evoked Ca^2+^ responses. (A) Cytosolic Ca^2+^ levels of TRPML1-expressing HeLa cells stimulated with 20 µM ML-SA1 in Ca^2+^-containing or Ca^2+^-free Hepes-buffered saline. (B) Summary data of experiments in A where each data point represents an independent repetition. The total number of cells analysed was 184--284. (C) Cytosolic Ca^2+^ levels of TRPML1 or TRPML1^D471K^-expressing HeLa cells stimulated with 20 µM ML-SA1 with or without 10 µM ML-SI3 in Ca^2+^-free medium. (D,E) Effect of disrupting Ca^2+^ stores on agonist-evoked Ca^2+^ responses. (D) Cytosolic Ca^2+^ levels of TRPML1-expressing HeLa cells stimulated with 20 µM ML-SA1 following pre-treatment with DMSO, 200 µM GPN, 1 µM thapsigargin or 100 µM 2-APB. (E) Summary data of experiments in D (71--462 cells). Experiments were performed in Ca^2+^-free medium.

We used the lysosomotropic agent Gly-Phe β-naphthylamide (GPN) to disrupt lysosomes. This dipeptide causes osmotic destabilisation of lysosomes and other cathepsin-C-positive compartments ([@JCS190322C21]). GPN treatment resulted in a rapid loss of Lysotracker^®^ red fluorescence consistent with its action on lysosomes ([Fig. S1E,F](Fig. S1E,F)) and inhibited the responses to ML-SA1 indicating a requirement for lysosomes in ML-SA1-evoked Ca^2+^ release ([Fig. 4](#JCS190322F4){ref-type="fig"}D). These data are consistent with the lysosomal localisation of TRPMLs ([Fig. 2](#JCS190322F2){ref-type="fig"}). However, despite the complete compromise of lysosomes upon GPN treatment, the resulting Ca^2+^ signals were modest relative to those evoked by ML-SA1 ([Fig. 4](#JCS190322F4){ref-type="fig"}D). This suggested that ML-SA1 did not exclusively release Ca^2+^ from the lysosomes.

We considered the possibility that activation of TRPMLs might be followed by Ca^2+^ release from the ER in a manner similar to activation of TPCs by NAADP ([@JCS190322C6]; [@JCS190322C35]). To test this, we examined the effects of ML-SA1 after depleting ER Ca^2+^ stores with thapsigargin. As shown in [Fig. 4](#JCS190322F4){ref-type="fig"}D, thapsigargin treatment blocked the responses to ML-SA1 indicating a clear requirement for ER Ca^2+^ stores in ML-SA1 action. To further probe the role of the ER, we used 2-APB to block inositol 1,4,5-trisphosphate (IP~3~) receptors. As shown in [Fig. 4](#JCS190322F4){ref-type="fig"}D, [2](#JCS190322F2){ref-type="fig"}-APB (100 µM) inhibited ML-SA1-evoked responses. A summary of these data is provided in [Fig. 4](#JCS190322F4){ref-type="fig"}E. We conclude that activation of TRPMLs on lysosomes triggers Ca^2+^ release from the ER.

TRPML1 mediates Ca^2+^ influx {#s2d}
-----------------------------

Finally, we examined the nature of the Ca^2+^ entry pathway evoked by TRPML1 activation. Because store-operated Ca^2+^ entry is a ubiquitous pathway underlying Ca^2+^ influx in non-excitable cells, we tested the effects of the Ca^2+^ entry inhibitor BTP2. BTP2 (20 µM) completely prevented Ca^2+^ signals evoked by Ca^2+^ add-back following depletion of ER Ca^2+^ stores with thapsigargin ([Fig. S2A,B](Fig. S2A,B)). However, BTP2 did not affect the amplitude of Ca^2+^ signals evoked by ML-SA1 ([Fig. 5](#JCS190322F5){ref-type="fig"}A,B) although it did slow the rate of rise ([Fig. S2C](Fig. S2C)). These data suggest that store-operated Ca^2+^ entry does not play a major role in Ca^2+^ signals evoked by TRPML1 activation. Fig. 5.**TRPML1 mediates Ca^2+^ influx.** (A,B) Effect of blocking store-operated Ca^2+^ influx on agonist-evoked Ca^2+^ responses. (A) Cytosolic Ca^2+^ levels of TRPML1-expressing HeLa cells stimulated with 20 µM ML-SA1 in the presence of vehicle (0.1% DMSO) or 20 µM BTP2. (B) Summary data of experiments in A where each data point represents an independent repetition. The total number of cells analysed was 151--173. (C--J) Effect of TRPML1 activation on Fe ion entry. HeLa cells expressing TRPML1 were stimulated with 20 µM ML-SA1 (C) or MK6-83 (E) and then 1 mM FeCl~2~ in the presence of vehicle (0.1% DMSO) or 10 µM ML-SI3. HeLa cells expressing TRPML1^D471K^ were stimulated with either 20 µM ML-SA1 or MK6-83 (G). HeLa cells expressing TRPML1 were stimulated with 20 µM ML-SA1 and either 1 mM FeCl~2~ or 1 mM FeCl~3~ (I). Experiments were performed in nominally Ca^2+^-free medium. Fluorescence signals (denoted F) were recorded after excitation at the isosbestic wavelength of Fura-2 (360 nm) and normalised to that at the beginning of recording (denoted F~0~). Summary data (D,F,H,J; for C,E,G and I, respectively) quantifying the fractional loss of fluorescence 144s after addition of Fe^2+^ or Fe^3+^ under the various conditions (80--169 cells).

The above data raised the possibility that TRPML1 might mediate Ca^2+^ entry more directly. To test this, we examined the effects of ML-SA1 on Fe^2+^ entry. Fe^2+^ permeates TRPML1 and, like several other metal ions, quenches Fura-2 fluorescence ([@JCS190322C11]). Fura-2-loaded HeLa cells were therefore challenged with FeCl~2~ (1 mM) in nominally Ca^2+^-free medium after stimulation with ML-SA1. FeCl~2~ induced a significant quench of Fura-2 fluorescence in cells expressing TRPML1 ([Fig. 5](#JCS190322F5){ref-type="fig"}C). This effect was blocked by ML-SI3 ([Fig. 5](#JCS190322F5){ref-type="fig"}C,D) and was not observed in cells expressing TRPML1^D471K^ ([Fig. 5](#JCS190322F5){ref-type="fig"}G,H). Similar results were obtained upon stimulation with MK6-83 ([Fig. 5](#JCS190322F5){ref-type="fig"}E--H). Challenge with FeCl~3~ (1 mM) after stimulation with ML-SA1 was without effect ([Fig. 5](#JCS190322F5){ref-type="fig"}I,J) attesting to specificity. BTP2 slowed Fe^2+^ entry ([Fig. S2D,E](Fig. S2D,E)), however, add-back of Fe^2+^ following depletion of Ca^2+^ stores with thapsigargin did not result in a significant quench ([Fig. S2F,G](Fig. S2F,G)).

Collectively, these data provide evidence that TRPML1 supports divalent cation entry across the plasma membrane.

DISCUSSION {#s3}
==========

In this study, we have shown that activation of TRPMLs by two structurally distinct agonists, in both a human cell line and primary cultures, evokes global Ca^2+^ signals. These data indicate that TRPMLs do not solely mediate local Ca^2+^ release events from endo-lysosomal compartments. Indeed, we provide evidence that activation of TRPMLs can evoke both Ca^2+^ release and Ca^2+^ entry.

We have dissected global Ca^2+^ release signals into both lysosomal and ER components. There is much evidence supporting the transmission of Ca^2+^ signals from endo-lysosomes to the ER but to date such 'chatter' has been ascribed exclusively to the actions of NAADP and TPCs ([@JCS190322C32]). Our study extends such coupling to TRPMLs, raising the possibility that other Ca^2+^-permeable endo-lysosomal channels such as P2X4 receptors and TRPM2 might also functionally couple to ER Ca^2+^ release channels ([@JCS190322C33]).

Inhibition of TRPML1 by plasma membrane PI(4,5)P~2~ is thought to ensure channel activation only in endo-lysosomal compartments ([@JCS190322C47]). In accordance with this idea, basal (unstimulated) whole-cell currents are not detectable in TRPML1-expressing cells. SF-51 ([@JCS190322C17]), the precursor to ML-SA1, however, has been reported to mediate a TRPML1 plasma membrane current ([@JCS190322C47]) consistent with our Ca^2+^ and Fe^2+^ entry measurements. Divalent cation entry might therefore result from targeting of a small fraction of TRPML1 to the plasma membrane. Although blockade of store-operated channels reduced TRPML1-dependent Ca^2+^ and Fe^2+^ entry (albeit modestly), the amplitude of the Ca^2+^ signal upon maximal Ca^2+^ ER store depletion was substantially smaller than that evoked by agonist activation. Indeed, store-operated Fe^2+^ entry was not demonstrable under our conditions. These data raise the possibility that BTP2 might directly inhibit TRPML1 similar to its effects on TRP-canonical (TRPC) channels ([@JCS190322C19]).

The multi-compartment actions of TRPML1 offer fresh perspective on interpreting Ca^2+^ signals recorded using Ca^2+^ reporters fused to TRPML1 ([@JCS190322C1]; [@JCS190322C7]; [@JCS190322C28]; [@JCS190322C40]). We suggest that such signals might additionally reflect Ca^2+^ release from the ER and Ca^2+^ entry. Indeed, defects in Ca^2+^ signals reported using such indicators in scenarios of TRPML1 dysfunction are perplexing given that expression of TRPML1 is able to rescue phenotypic defects such as lysosomal storage ([@JCS190322C7]; [@JCS190322C40]). Use of inert lysosomal proteins for targeting ([@JCS190322C27]) and/or low-affinity Ca^2+^ indicators, to better insulate against bulk cytosolic Ca^2+^ changes, might aid in isolating local lysosomal Ca^2+^ release events. Finally, how TRPMLs are endogenously activated remains to be established, but PI(3,5)P~2~ is a clear candidate raising the possibility that changes in its levels in response to cues such as growth factors might regulate global Ca^2+^ dynamics.

MATERIALS AND METHODS {#s4}
=====================

Cell culture {#s4a}
------------

HeLa cells and primary cultured human skin fibroblasts from healthy individuals ([@JCS190322C22]) were maintained in Dulbecco\'s modified Eagle\'s medium (DMEM) supplemented with 10% (v/v) fetal bovine serum, 100 units/ml penicillin and 100 µg/ml streptomycin (all from Invitrogen) at 37°C in a humidified atmosphere with 5% CO~2~. Cells were passaged using trypsin (HeLa) or scraping (fibroblasts) and plated onto 13-mm glass coverslips prior to microscopy. For HeLa cells, coverslips were coated with poly-L-lysine (Sigma). Cells were transfected with plasmids using Lipofectamine 2000 according to the manufacturer\'s instructions. Plasmids encoding the following proteins were described previously: C-terminally GFP-tagged LAMP1 ([@JCS190322C13]), C-terminally mRFP-tagged LAMP1 ([@JCS190322C41]) and N-terminally GFP-tagged wild-type or D471K human TRPML1 ([@JCS190322C45]).

Cell labelling {#s4b}
--------------

All live imaging experiments were performed in HEPES-buffered saline (HBS) comprising (in mM): 1.25 KH~2~PO~4~, 2 CaCl~2~, 2 MgSO~4~, 3 KCl, 156 NaCl, 10 glucose, and 10 HEPES (pH 7.4; all from Sigma). For measurement of cytosolic Ca^2+^ concentration and Fe^2+^ or Fe^3+^ entry, cells were incubated with Fura-2 AM (2.5 µM) and 0.005% v/v pluronic acid (from Invitrogen) for 1 h. For measurement of lysosome distribution, cells were incubated with Lysotracker^®^ Red (100 nM) (Invitrogen) for 15 min. After labelling, cells were washed with HBS and mounted in a 1-ml imaging chamber (Biosciences Tools) prior to microscopy. For measurement of colocalisation, cells were co-transfected with GFP--TRPML1 or GFP--TRPML1^D471K^ together with LAMP1--mRFP and fixed with 4% paraformaldehyde prior to confocal microscopy. For visualisation of nuclei, cells were incubated with 1 µg/ml DAPI for 5 min.

Epifluorescence microscopy {#s4c}
--------------------------

Epifluorescence images were captured every 3 s with a cooled coupled device camera (TILL photonics) attached to an Olympus IX71 inverted fluorescence microscope fitted with a 20× objective, and a monochromator light source. Fura-2 was excited at 340, 360 or 380 nm, and Lysotracker^®^ Red at 560 nm. Emitted fluorescence was captured using a 440-nm long-pass filter (Fura-2) and 590-nm filter (Lysotracker^®^ Red). TRPML1-expressing cells were identified by monitoring fluorescence of GFP (excitation 488 nm, emission 505 nm). Cells were stimulated with ML-SA1, GW405833 hydrochloride (Sigma; also known as ML-SI1, Haoxing Xu, Department of Molecular, Cellular, and Developmental Biology, University of Michigan, USA, personal communication), ML-SI3 (a kind gift from Haoxing Xu), MK6-83 synthesised as described previously ([@JCS190322C8]), GPN (Santa Cruz Biotechnology), BTP2 (Sigma), thapsigargin (Merck), 2-aminoethoxydiphenyl borate (2-APB, Sigma). Where indicated, Ca^2+^ was omitted from the HBS (nominally Ca^2+^-free) or replaced with 1 mM EGTA (Ca^2+^-free). For Fe^2+^ or Fe^3+^ quench experiments, cells were stimulated using freshly prepared 100 mM stock solutions of either FeCl~2~ or FeCl~3~ (Sigma). The maximal fluorescence ratio change (Ca^2+^) or the fractional quench at 360 nm excitation (Fe^2+^ or Fe^3+^) were quantified on an individual cell basis and averaged for all cells in a given field of view. Experiments were repeated at least three times and all individual data points plotted. The total number of cells analysed is stated in the legends.

Confocal microscopy {#s4d}
-------------------

Confocal images were captured using an LSM510 confocal scanner (Zeiss) attached to a Zeiss Axiovert 200M inverted microscope fitted with a 63× Plan Apochromat water-immersion objective. DAPI, GFP and Lysotracker^®^ Red or mRFP were excited at 364 nm, 488 nm and 543 nm, and emitted fluorescence was captured using 385--470 nm, 505--550 nm and 560--615 nm band-pass filters, respectively. Pearson\'s correlation coefficients were calculated from *z*-stacks (1-µm intervals, 8--12 slices) using the ImageJ plugin Coloc2. The fraction of colocalised vesicles was calculated from the middle slice or slices using the ImageJ plugin SQUASSH.
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